Fluvoxamine shows promise for long COVID fatigue in clinical trial
A randomized clinical trial of 399 adults found that the low-cost antidepressant fluvoxamine significantly reduced fatigue and improved quality of life in people struggling with long COVID symptoms.
·1 source
